echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Nat Commun: Scientists Find Obesity Induces Islet Inflammation!

    Nat Commun: Scientists Find Obesity Induces Islet Inflammation!

    • Last Update: 2022-05-23
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    As a marker of obesity, low-grade tissue inflammation is manifested in various organs such as adipose tissue, liver, muscle, and pancreatic islets
    .
    Chronic islet inflammation exists in both obese mouse models of type 2 diabetes (T2DM) and obese/T2DM patients
    .
    This obesity-induced islet inflammation can lead to the β-cell abnormalities characteristic of T2DM
    .
    Leakage of various microbial products from the gut has been shown to exacerbate tissue inflammation and metabolic disturbances in obese patients
    .
    Vsig4+ macrophages are key to preventing the infiltration of bacteria and their products into host tissues
    .
    However, the regulatory role of islet Vsig4+ macrophages between the microbiota and β cells in the pathogenesis of obesity-related islet abnormalities remains unclear
    .
    A research paper titled "Accumulation of microbial DNAs promotes to islet inflammation and β cell abnormalities in obesity in mice" published on Nat Commun specifically elucidates this mechanism
    .
     
     
    The researchers first used 16s rRNA probes to detect the abundance of bacterial DNA in the pancreas of healthy individuals or obese/T2DM patients and found that bacterial DNA was enriched in pancreatic beta cells of obese hosts; in addition, in the case of obesity, microbial DNA was contained The extracellular vesicles (mEVs) can reach the host pancreas through the intestinal barrier
    .
    The researchers analyzed the important role of Vsig4+ macrophages in preventing islet mEV infiltration and found that Vsig4+ macrophages prevented islet infiltration of intestinal mEVs
    .
    Since microbial-derived products can exacerbate tissue inflammation and metabolic disturbances in obese patients, we assessed whether accumulation of bacterial DNA triggers islet inflammation and beta-cell dysfunction, and investigated the effect of obese mEVs on triggering islet inflammation and beta-cell abnormalities.
    We found that microbial-derived EVs contribute to obesity-related islet inflammation and β-cell abnormalities, and that obese mEVs can trigger islet inflammation and β-cell dysfunction in the absence of Vsig4+ macrophages
    .
    In addition, they assessed whether islet Vsig4+ macrophages can effectively protect islets from the pathogenic effects of intestinal mEV in the absence of liver Vsig4+ macrophages, and the results show that islet Vsig4+ macrophages are sufficient to block intestinal mEV pathogenic effect
    .
    In addition, the researchers also found that microbial DNA is a key pathogenic vector for islet dysfunction in intestinal EVs in obese patients
    .
    Microbial DNA promotes activation of the cGAS/STING pathway and triggers islet inflammation; Vsig4+ macrophages prevent mEV infiltration into β cells through c3-dependent opsonization, while Vsig4 deletion results in enrichment of microbial DNA in β cells after mEV treatment
    .
    Bacterial DNA was found to be enriched in pancreatic beta cells of obese hosts; moreover, in the presence of obesity, extracellular vesicles (mEVs) containing microbial DNA could cross the gut barrier to reach the host pancreas
    .
    Vsig4+ macrophages were found to prevent islet infiltration of intestinal mEVs
    .
    We found that microbial-derived EVs contribute to obesity-related islet inflammation and β-cell abnormalities, and that obese mEVs can trigger islet inflammation and β-cell dysfunction in the absence of Vsig4+ macrophages
    .
    The results suggest that islet Vsig4+ macrophages are sufficient to block the pathogenic effects of intestinal mEVs
    .
    In addition, the researchers also found that microbial DNA is a key pathogenic vector for islet dysfunction in intestinal EVs in obese patients
    .
    Microbial DNA promotes activation of the cGAS/STING pathway and triggers islet inflammation; Vsig4+ macrophages prevent mEV infiltration into β cells through c3-dependent opsonization, while Vsig4 deletion results in enrichment of microbial DNA in β cells after mEV treatment
    .
     
    Figure Obesity mEVs contribute to obesity-related islet inflammation and β-cell abnormalities
     
    This study specifically elucidates the mechanism of action of islet Vsig4+ macrophages in preventing obesity-related islet inflammation and abnormal development of beta cells
    .
    This study specifically elucidates the mechanism of action of islet Vsig4+ macrophages in preventing obesity-related islet inflammation and abnormal development of beta cells
    .
     
    Reference: Gao, H.
    , Luo, Z.
    , Ji, Y.
    et al.
    Accumulation of microbial DNAs promotes to islet inflammation and β cell abnormalities in obesity in mice.
    Nat Commun 13, 565 (2022).
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.